scispace - formally typeset
J

Julia I-Ju Leu

Researcher at University of Pennsylvania

Publications -  33
Citations -  6706

Julia I-Ju Leu is an academic researcher from University of Pennsylvania. The author has contributed to research in topics: Liver regeneration & Gene. The author has an hindex of 17, co-authored 30 publications receiving 6015 citations. Previous affiliations of Julia I-Ju Leu include Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

An African-specific polymorphism in the TP53 gene impairs p53 tumor suppressor function in a mouse model

TL;DR: The S47 variant exhibits a modest decrease in apoptosis in response to most genotoxic stresses compared with wild-type p53 but exhibits a significant defect in cell death induced by cisplatin, and the potential relevance of metabolism and ferroptosis to tumor suppression by p53 is confirmed.
Journal ArticleDOI

Interleukin-6-induced STAT3 and AP-1 amplify hepatocyte nuclear factor 1-mediated transactivation of hepatic genes, an adaptive response to liver injury.

TL;DR: The results demonstrate that the two classes of transcription factors, growth induced (STAT3 and AP-1) and tissue specific (HNF-1), can interact as an adaptive response to liver injury to amplify expression of hepatic genes important for the homeostatic response during organ repair.
Journal ArticleDOI

Massive hepatic apoptosis associated with TGF-β1 activation after Fas ligand treatment of IGF binding protein-1–deficient mice

TL;DR: Findings indicate that IGFBP-1 functions as a critical hepatic survival factor in the liver by reducing the level of proapoptotic signals.
Journal ArticleDOI

Impaired Hepatocyte DNA Synthetic Response Posthepatectomy in Insulin-Like Growth Factor Binding Protein 1-Deficient Mice with Defects in C/EBPβ and Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Regulation

TL;DR: The first demonstration of the involvement of IGFBP-1 in the regulation of in vivo mitogenic signaling pathways is demonstrated, suggesting that IGF BP-1 may support liver regeneration at least in part via its effect on MAPK/ERK and C/EBPβ activities.